The Effect of Oral Pleconaril on Hepatic Cytochrome P450 3A Activity in Healthy Adults Using Intravenous Midazolam as a Probe
- 1 January 2006
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 46 (1), 103-108
- https://doi.org/10.1177/0091270005283286
Abstract
Pleconaril is a viral capsid inhibitor under evaluation for treatment of infections caused by rhinoviruses and enteroviruses. This study evaluated the effect of pleconaril on hepatic cytochrome P450 (CYP) 3A activity as assessed by intravenous (IV) midazolam. Healthy adults received oral pleconaril 400 mg 3 times daily for 16 doses. Single‐dose, IV midazolam 0.025 mg/kg was administered before and during pleconaril administration. Midazolam and pleconaril plasma concentrations were assayed by LC/MS/MS. Bioequivalence was assessed by least squares geometric mean ratios (LS‐GMR) with 90% confidence intervals (90% CIs) for the measured midazolam pharmacokinetic parameters. Sixteen subjects were enrolled, and 14 subjects completed the study. Pleconaril decreased midazolam AUC0‐∞ 28% and increased systemic clearance 39%. LS‐GMR (90% CI) were 0.718 (0.674–0.765) and 1.392 (1.307–1.483), respectively. Plasma pleconaril concentrations steadily increased over time. Observed changes in midazolam AUC0‐∞ and systemic clearance suggest that oral pleconaril increased hepatic CYP3A activity in healthy adults.Keywords
This publication has 33 references indexed in Scilit:
- An Evaluation of the Dose‐Dependent Inhibition of CYP1A2 by Rofecoxib Using Theophylline as a CYP1A2 ProbeThe Journal of Clinical Pharmacology, 2003
- THE HUMAN CYP3A SUBFAMILY: PRACTICAL CONSIDERATIONS*Drug Metabolism Reviews, 2000
- Inhibition and Induction of Cytochrome P450 and the Clinical ImplicationsClinical Pharmacokinetics, 1998
- Endotoxin depresses hepatic cytochrome P450‐mediated drug metabolism in womenBritish Journal of Clinical Pharmacology, 1997
- Regulation of Cytochromes P450 During Inflammation and InfectionDrug Metabolism Reviews, 1997
- Enteroviral Infections of the Central Nervous SystemClinical Infectious Diseases, 1995
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Interleukin-1 (IL-1) depresses cytochrome P450 levels and activities in miceLife Sciences, 1987
- Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in miceBiochemical and Biophysical Research Communications, 1986
- Temporal and Geographic Patterns of Isolates of Nonpolio Enterovirus in the United States, 1970-1983The Journal of Infectious Diseases, 1986